Online HML - December 2021


You are viewing December 2021. View November 2021 Schedule.

Monoclonal Antibodies
Bevacizumab Inj 25 mg per ml, 4 ml vial; Inj 25 mg per ml, 16 ml vial
Ranibizumab Inj 10 mg per ml, 0.23 ml vial; Inj 10 mg per ml, 0.3 ml vial
Infliximab Inj 100 mg
Tocilizumab Inj 20 mg per ml, 4 ml vial; Inj 20 mg per ml, 10 ml vial; Inj 20 mg per ml, 20 ml vial
Omalizumab Inj 150 mg prefilled syringe; Inj 150 mg vial
Siltuximab Inj 100 mg vial; Inj 400 mg vial
Obinutuzumab Inj 25 mg per ml, 40 ml vial
Pertuzumab Inj 30 mg per ml, 14 ml vial
Cetuximab Inj 5 mg per ml, 20 ml vial; Inj 5 mg per ml, 100 ml vial
Aflibercept Inj 40 mg per ml, 0.1 ml vial
Secukinumab Inj 150 mg per ml, 1 ml prefilled syringe
Trastuzumab emtansine Inj 100 mg vial; Inj 160 mg vial
Rituximab (riximyo) Inj 10 mg per ml, 10 ml vial; Inj 10 mg per ml, 50 ml vial
Mepolizumab Inj 100 mg prefilled pen; Inj 100 mg vial
Basiliximab Inj 20 mg vial
Rituximab (mabthera) Inj 10 mg per ml, 10 ml vial; Inj 10 mg per ml, 50 ml vial
Trastuzumab Inj 150 mg vial; Inj 440 mg vial
Adalimumab Inj 20 mg per 0.4 ml syringe; Inj 40 mg per 0.8 ml pen; Inj 40 mg per 0.8 ml syringe
Abciximab Inj 2 mg per ml, 5 ml vial